ALPINE WOODS CAPITAL INVESTORS, LLC - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 144 filers reported holding THERAPEUTICSMD INC in Q4 2017. The put-call ratio across all filers is 2.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALPINE WOODS CAPITAL INVESTORS, LLC ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q3 2019$145,000
+39.4%
40,0000.0%0.03%
+22.7%
Q2 2019$104,000
-46.7%
40,0000.0%0.02%
-47.6%
Q1 2019$195,000
+200.0%
40,000
+135.3%
0.04%
+162.5%
Q4 2018$65,000
-42.0%
17,0000.0%0.02%
-30.4%
Q3 2018$112,000
+5.7%
17,0000.0%0.02%0.0%
Q2 2018$106,000
+82.8%
17,000
+41.7%
0.02%
+666.7%
Q1 2018$58,000
-19.4%
12,0000.0%0.00%
-25.0%
Q4 2017$72,000
+12.5%
12,0000.0%0.00%
+33.3%
Q3 2017$64,000
+1.6%
12,0000.0%0.00%0.0%
Q2 2017$63,000
-26.7%
12,0000.0%0.00%
-40.0%
Q1 2017$86,000
+24.6%
12,0000.0%0.01%
+25.0%
Q4 2016$69,000
-15.9%
12,0000.0%0.00%
-20.0%
Q3 2016$82,000
-19.6%
12,0000.0%0.01%
-16.7%
Q2 2016$102,0000.0%12,000
-25.0%
0.01%0.0%
Q1 2016$102,000
-38.6%
16,0000.0%0.01%
-33.3%
Q4 2015$166,000
-5.7%
16,000
-46.7%
0.01%
-10.0%
Q3 2015$176,000
-25.4%
30,0000.0%0.01%
-16.7%
Q2 2015$236,000
+29.7%
30,0000.0%0.01%
+33.3%
Q1 2015$182,000
+70.1%
30,000
+25.0%
0.01%
+80.0%
Q4 2014$107,000
-3.6%
24,0000.0%0.01%
-16.7%
Q3 2014$111,000
+4.7%
24,000
-0.1%
0.01%
+100.0%
Q2 2014$106,00024,0200.00%
Other shareholders
THERAPEUTICSMD INC shareholders Q4 2017
NameSharesValueWeighting ↓
VHCP Management, LLC 846,500$3,742,0002.00%
RA Capital Management 4,303,066$19,020,0001.92%
Ghost Tree Capital, LLC 250,000$1,105,0000.78%
Century Capital Management, LLC 1,906,082$8,425,0000.44%
Granite Point Capital Management, L.P. 120,000$530,0000.36%
GILDER GAGNON HOWE & CO LLC 6,136,366$27,123,0000.36%
OUTFITTER ADVISORS, LTD. 180,802$799,0000.30%
STONERIDGE INVESTMENT PARTNERS LLC 422,681$1,868,0000.28%
Trellus Management Company, LLC 36,400$161,0000.14%
Nicholas Investment Partners, LP 524,544$2,318,0000.14%
View complete list of THERAPEUTICSMD INC shareholders